Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

121.19
Delayed Data
As of Aug 18
 -0.55 / -0.45%
Today’s Change
75.52
Today|||52-Week Range
153.15
+20.86%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close121.74
Today’s open121.60
Day’s range121.00 - 122.47
Volume958,477
Average volume (3 months)1,647,057
Market cap$24.9B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-256.42%
Earnings growth (next 5 years)+92.90%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book54.56

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.15-0.25%
ALXNAlexion Pharmaceutic...-1.23-0.91%
BAXBaxter International...+0.05+0.08%
MYLMylan NV+0.16+0.52%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts